Taro Pharmaceutical Industries Ltd (Taro) discovers, develops and markets healthcare products. The company manufactures prescription drugs, non-prescription drugs and active pharmaceutical ingredients (APIs). It develops pharmaceutical products in semi-solids formulations, such as ointments and creams and other dosage forms including liquids, capsules and tablets. Taro develops products in dermatological and topical, neuropsychiatric, anti-inflammatory and cardiovascular areas. The company sells and distributes its product to healthcare institutions, drug store chains, and private pharmacies. It has presence in Israel, the US, Canada and other countries. The company markets over 200 pharmaceutical products in more than 20 countries worldwide. Taro is headquartered in Haifa Bay, Israel.